News & Updates
Filter by Specialty:
Xanomeline–trospium beneficial in treatment of schizophrenia
Treatment with the combination of xanomeline plus trospium leads to favourable reduction in positive and negative symptoms in patients with schizophrenia, while being well tolerated, according to data from the phase III EMERGENT-2 trial.
Xanomeline–trospium beneficial in treatment of schizophrenia
16 Jan 2024
NIH study: Semaglutide associated with lower risk of suicidal ideation
Semaglutide is associated with a 49─73 percent lower risk of suicidal ideation vs other agents for treatment of obesity and type 2 diabetes mellitus (T2DM), a National Institutes of Health (NIH)─funded study has shown.
NIH study: Semaglutide associated with lower risk of suicidal ideation
11 Jan 2024
One in five community-dwelling older adults has mild neurocognitive disorders
Mild neurocognitive disorders (NCDs) are present in one in five community-dwelling older adults in Hong Kong, while 70 percent of older adults living in residential care homes have dementia, researchers from the Chinese University of Hong Kong (CUHK) have reported.
One in five community-dwelling older adults has mild neurocognitive disorders
04 Jan 2024
Novel probiotics may improve mood disorder symptoms and sleep quality
A novel multi-strain E3 probiotic formulation improves symptoms of depression and anxiety as well as sleep quality, a prospective cohort study has shown.
Novel probiotics may improve mood disorder symptoms and sleep quality
29 Dec 2023
Minority healthcare workers more exposed to COVID-19‒related stressors
Healthcare workers belonging to racial and ethnic minorities show greater exposure to several COVID-19‒related stressors, indicating a structural racism in the workforce, reports a study.
